Ginkgolic Acid as a carbapenem synergist against KPC-2 positive Klebsiella pneumoniae
The successful evolution of KPC-2 in bacteria has limited the clinical practice of carbapenems. This dilemma deteriorated the prognosis of associated infections and hence attracted increasing attention from researchers to explore alternative therapeutic options. Here, the enzyme inhibition assay was...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2024-08-01
|
| Edice: | Frontiers in Microbiology |
| Témata: | |
| On-line přístup: | https://www.frontiersin.org/articles/10.3389/fmicb.2024.1426603/full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|